- $53.39m
- $7.36m
- $37.25m
Brief: Eargo Files For Resale Of Up To 316.43 Mln Shares Of Common Stock
Brief: Eargo Inc - On December 12, 2022 Co Received Letter From Nasdaq That It Had Regained Compliance With The Relevant Nasdaq Listing Rule - Filing
Brief: Nationsbenefits And Eargo Announce Partnership To Offer Over-The-Counter Hearing Aids
Brief: Eargo Announces Strategic Additions To Board Of Directors Following Patient Square Capital Becoming New Majority Shareholder
Brief: Eargo Inc Says Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing
Brief: Eargo Announces Issuance Of Quarterly Report For Third Fiscal Quarter
Eargo Inc reports results for the quarter ended in September - Earnings Summary
Eargo Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Eargo Announces Commencement Of Rights Offering
Brief: Eargo Announces Record Date For Proposed Rights Offering
Eargo up as FDA allows sale of over-the-counter hearing aids
U.S. STOCKS ON THE MOVE-Atara Bio, Novavax, Micron, Norwegian Cruise
U.S. STOCKS ON THE MOVE-Applied DNA, Verona Pharma, SELLAS
U.S. STOCKS ON THE MOVE-Capri Holdings, Mersana, Vivid Seats
U.S. STOCKS ON THE MOVE-Boeing, Occidental Petroleum, Bed Bath & Beyond
Eargo falls as Q2 loss widens, revenue falls
Brief: Eargo Reports Second Quarter 2022 Financial Results
Eargo Inc reports results for the quarter ended in June - Earnings Summary
Highly shorted Bed Bath & Beyond extends gains